Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-propofol versus ketamine-thiopental anesthesia during ECT for refractory major depression
IRCT20211009052708N1Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Oct 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ketamine, propofol, thiopental and atropine in major depressive disorder (MDD) (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoint: Depression. Started Oct 2021; status: completed.
02
Drugs
ketaminepropofolthiopentalatropine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20211009052708N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211009052708N1.